Survivin selectively modulates genes deregulated in human leukemia stem cells

Journal of Oncology

Volumn , Issue , 2011, Pages

  Fukuda, Seiji ^a,b   Abe, Mariko ^a   Onishi, Chie ^a   Taketani, Takeshi ^a,c   Purevsuren, Jamiyan ^a   Yamaguchi, Seiji ^a   Conway, Edward M ^d   Pelus, Louis M ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b INDIANA UNIVERSITY   (United States)

^c SHIMANE UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CD34 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; SURVIVIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; GENE CONTROL; GENE DELETION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C KIT; SIGNAL TRANSDUCTION;

EID: 79952241213     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/946936     Document Type: Article

References (35)

1. Altieri D. C., Survivin, versatile modulation of (Pubitemid 38019195)
2. Altieri D. C., Validating survivin as a cancer therapeutic target Nature Reviews Cancer 2003 3 1 46 54 (Pubitemid 37328886)
3. Fukuda S., Pelus L. M., Survivin, a cancer target with an emerging role in normal adult tissues Molecular Cancer Therapeutics 2006 5 5 1087 1098 (Pubitemid 43881300)
4. Fukuda S., Foster R. G., Porter S. B., Pelus L. M., The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells Blood 2002 100 7 2463 2471
5. Fukuda S., Pelus L. M., Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry Cell Cycle 2002 1 5 322 326
6. Fukuda S., Pelus L. M., Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis Blood 2001 98 7 2091 2100
7. Fukuda S., Mantel C. R., Pelus L. M., Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent andindependent pathways Blood 2004 103 1 120 127 (Pubitemid 38029926)
8. Leung C. G., Xu Y., Mularski B., Liu H., Gurbuxani S., Crispino J. D., Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells Journal of Experimental Medicine 2007 204 7 1603 1611 (Pubitemid 47048027)
9. Carter B. Z., Milella M., Altieri D. C., Andreeff M., Cytokine-regulated expression of survivin in myeloid leukemia Blood 2001 97 9 2784 2790
10. Adida C., Recher C., Raffoux E., Daniel M.-T., Taksin A.-L., Rousselot P., Sigaux F., Degos L., Altieri D. C., Dombret H., Expression and prognostic significance of survivin in de novo acute myeloid leukaemia British Journal of Haematology 2000 111 1 196 203
11. Badran A., Yoshida A., Wano Y., Mutoh M., Imamura S., Yamashita T., Tsutani H., Inuzuka M., Ueda T., Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome International Journal of Oncology 2003 22 1 59 64
12. Gilliland D. G., Griffin J. D., The roles of FLT3 in hematopoiesis and leukemia Blood 2002 100 5 1532 1542 (Pubitemid 34925124)
13. Levis M., Murphy K. M., Pham R., Kim K.-T., Stine A., Li L., McNiece I., Smith B. D., Small D., Internal tandem duplications of the FLT3 gene are present in leukemia stem cells Blood 2005 106 2 673 680 (Pubitemid 40981265)
14. Fukuda S., Singh P., Moh A., Abe M., Conway E. M., Scott Boswell H., Yamaguchi S., Fu X.-Y., Pelus L. M., Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3 Blood 2009 114 2 394 403
15. Velculescu V. E., Madden S. L., Zhang L., Lash A. E., Yu J., Rago C., Lal A., Wang C. J., Beaudry G. A., Ciriello K. M., Cook B. P., Dufault M. R., Ferguson A. T., Gao Y., He T.-C., Hermeking H., Hiraldo S. K., Hwang P. M., Lopez M. A., Luderer H. F., Mathews B., Petroziello J. M., Polyak K., Zawel L., Zhang W., Zhang X., Zhou W., Haluska F. G., Jen J., Sukumar S., Landes G. M., Riggins G. J., Vogelstein B., Kinzler K. W., Analysis of human transcriptomes Nature Genetics 1999 23 4 387 388
16. Majeti R., Becker M. W., Tian Q., Lee T.-L. M., Yan X., Liu R., Chiang J.-H., Hood L., Clarke M. F., Weissman I. L., Dysregulated gene expression networks in human acute myelogenous leukemia stem cells Proceedings of the National Academy of Sciences of the United States of America 2009 106 9 3396 3401
17. Kelly L. M., Liu Q., Kutok J. L., Williams I. R., Boulton C. L., Gilliland D. G., FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model Blood 2002 99 1 310 318
18. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nature Protocols 2009 4 1 44 57
19. Cline M. S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., Christmas R., Avila-Campilo I., Creech M., Gross B., Hanspers K., Isserlin R., Kelley R., Killcoyne S., Lotia S., Maere S., Morris J., Ono K., Pavlovic V., Pico A. R., Vailaya A., Wang P. L., Adler A., Conklin B. R., Hood L., Kuiper M., Sander C., Schmulevich I., Schwikowski B., Warner G. J., Ideker T., Bader G. D., Integration of biological networks and gene expression data using Cytoscape Nature Protocols 2007 2 10 2366 2382
20. Ivanova N. B., Dimos J. T., Schaniel C., Hackney J. A., Moore K. A., Lemischka I. R., A stem cell molecutar signature Science 2002 298 5593 601 604 (Pubitemid 35215314)
21. Asanuma K., Tsuji N., Endoh T., Yagihashi A., Watanabe N., Survivin enhances fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells The Journal of Immunology 2004 172 6 3922 3929 (Pubitemid 38337980)
22. Takizawa B. T., Uchio E. M., Cohen J. J., Wheeler M. A., Weiss R. M., Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells Cancer Investigation 2007 25 8 678 684 (Pubitemid 350223166)
23. Balkhi M. Y., Christopeit M., Chen Y., Geletu M., Behre G., AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation Experimental hematology 2008 36 11 1449 1460
24. Salz W., Eisenberg D., Plescia J., Garlick D. S., Weiss R. M., Wu X.-R., Sun T.-T., Altieri D. C., A survivin gene signature predicts aggressive tumor behavior Cancer Research 2005 65 9 3531 3534 (Pubitemid 40616325)
25. Kostrouchova M., Kostrouch Z., Saudek V., Piatigorsky J., Rall J. E., BIR-1, a Caenorhabditis elegans homologue of Survivin, regulates transcription and development Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5240 5245 (Pubitemid 36542689)
26. Chen J., Jin S., Tahir S. K., Zhang H., Liu X., Sarthy A. V., McGonigal T. P., Liu Z., Rosenberg S. H., Ng S.-C., Survivin enhances aurora-B kinase activity and localizes aurora-B in human cells The Journal of Biological Chemistry 2003 278 1 486 490 (Pubitemid 36043600)
27. Bolton M. A., Lan W., Powers S. E., McCleland M. L., Kuang J., Stukenberg P. T., Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation Molecular Biology of the Cell 2002 13 9 3064 3077 (Pubitemid 35034246)
28. Nowak S. J., Corces V. G., Phosphorylation of histone H3 correlates with transcriptionally active loci Genes and Development 2000 14 23 3003 3013
29. Li J., Lin Q., Yoon H.-G., Huang Z.-Q., Strahl B. D., Allis C. D., Wong J., Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor Molecular and Cellular Biology 2002 22 16 5688 5697 (Pubitemid 34815819)
30. Cheung P., Tanner K. G., Cheung W. L., Sassone-Corsi P., Denu J. M., Allis C. D., Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation Molecular Cell 2000 5 6 905 915
31. Wei Y., Yu L., Bowen J., Gorovsky M. A., David Allis C., Phosphorylation of histone H3 is required for proper chromosome condensation and segregation Cell 1999 97 1 99 109 (Pubitemid 29165893)
32. Alvarez R. H., Valero V., Hortobagyi G. N., Emerging targeted therapies for breast cancer Journal of Clinical Oncology 2010 28 20 3366 3379
33. Harris T. J.R., McCormick F., The molecular pathology of cancer Nature Reviews Clinical Oncology 2010 7 5 251 265
34. Hahn C. K., Berchuck J. E., Ross K. N., Kakoza R. M., Clauser K., Schinzel A. C., Ross L., Galinsky I., Davis T. N., Silver S. J., Root D. E., Stone R. M., DeAngelo D. J., Carroll M., Hahn W. C., Carr S. A., Golub T. R., Kung A. L., Stegmaier K., Proteomic and genetic approaches identify Syk as an AML target Cancer Cell 2009 16 4 281 294
35. Boehrer S., Ads L., Braun T., Galluzzi L., Grosjean J., Fabre C., Le Roux G., Gardin C., Martin A., De Botton S., Fenaux P., Kroemer G., Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study Blood 2008 111 4 2170 2180 (Pubitemid 351451531)